TLQP-21 (Human) [8349]
TLQP-21 (Human)
| SMILES | CC(C)CC(NC(=O)C(N)C(C)O)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)O |
| InChIKey | PWWMOXVVMRPYJS-UHFFFAOYSA-N |
| Sequence | XLQPPASSRRRHFHHALPPAR |
| HELM | PEPTIDE1{[*C(=O)C(C(C)O)N |$_R2;;;;;;;$|].(L,[dL]).(Q,[dQ]).(P,[dP]).(P,[dP]).(A,[dA]).(S,[dS]).(S,[dS]).(R,[dR]).(R,[dR]).(R,[dR]).(H,[dH]).(F,[dF]).(H,[dH]).(H,[dH]).(A,[dA]).(L,[dL]).(P,[dP]).(P,[dP]).(A,[dA]).(R,[dR])}$$$$V2.0 |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
TLQP-21 (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|